If you liked Real-World Evidence Generation and Evaluation of Therapeutics by Health and Medicine Division, Board on Health Sciences Policy, and Anne B. Claiborne, start with Measuring Trauma (2016), Health Professions Faculty for the Future (2021), and Toward Equitable Innovation in Health and Medicine (2024). These recommendations are drawn from the same author, shared genres, and reader overlap on BookOrb.
Back to Real-World Evidence Generation and Evaluation of Therapeutics
· Health and Medicine Division books in order
Recommended next reads
-
1
Measuring Trauma
2016 · 84 pages · Health and Medicine Division, Board on Health Sciences Policy, Division of Behavioral and Social Sciences and Education, Cognitive, and Sensory Sciences Board on Behavioral · Same author
-
2
Health Professions Faculty for the Future
2021 · 86 pages · Health and Medicine Division, Global Forum on Innovation in Health Professional Education, Erin Hammers Forstag · Same author
-
3
Toward Equitable Innovation in Health and Medicine
2024 · 242 pages · National Academy of Medicine, Health and Medicine Division, Board on Health Sciences Policy, Committee on Creating a Framework for Emerging Science, Technology, and Innovation in Health and Medicine · Same author
-
4
Envisioning a Transformed Clinical Trials Enterprise For 2030
2022 · 138 pages · Health and Medicine Division, Board on Health Sciences Policy, Carolyn Shore · Same author
-
5
Environmental Neuroscience : Advancing the Understanding of How Chemical Exposures Impact Brain Health and Disease
2020 · 86 pages · Division on Earth and Life Studies, Health and Medicine Division, Board on Health Sciences Policy · Same author
-
6
Understanding and Offsetting Financial Barriers for Black Students in Science, Engineering, and Medicine : Programs, Partnerships, and Pathways
2022 · 110 pages · Health and Medicine Division, Policy and Global Affairs, Roundtable on Black Men and Black Women in Science, Engineering, and Medicine, Cato T. Laurencin · Same author
-
7
Intergenerational Poverty and Mobility among Native Americans in the United States
2023 · 54 pages · Health and Medicine Division, Division of Behavioral and Social Sciences and Education, Youth, and Families Board on Children, Committee on Policies and Programs to Reduce Intergenerational Poverty · Same author
-
8
Innovation in Drug Research and Development for Prevalent Chronic Diseases
2021 · 112 pages · Health and Medicine Division, Board on Health Sciences Policy, Carolyn Shore · Same author
-
9
Enhancing the Vitality of the National Institutes of Health
2003 · 164 pages · Board on Health Sciences Policy, Division on Earth and Life Studies, Board on Life Sciences · Same author
-
10
Current Status and Response to the Global Obesity Pandemic
2019 · 100 pages · Health and Medicine Division, Roundtable on Obesity Solutions, Emily A. Callahan · Same author
-
11
Health Disparities in the Medical Record and Disability Determinations
2024 · 144 pages · Health and Medicine Division, Joe Alper, Austen Applegate · Same author
-
12
Reassessment of the Department of Veterans Affairs Airborne Hazards and Open Burn Pit Registry
2023 · 292 pages · Health and Medicine Division, Committee on the Reassessment of the Department of Veterans Affairs Airborne Hazards and Open Burn Pit Registry · Same author
Frequently asked questions
What should I read after Real-World Evidence Generation and Evaluation of Therapeutics?
BookOrb recommends Measuring Trauma (2016), Health Professions Faculty for the Future (2021), Toward Equitable Innovation in Health and Medicine (2024), Envisioning a Transformed Clinical Trials Enterprise For 2030 (2022), and Environmental Neuroscience : Advancing the Understanding of How Chemical Exposures Impact Brain Health and Disease (2020).
Are there books like Real-World Evidence Generation and Evaluation of Therapeutics?
Yes. The list on this page is ranked from the closest matches BookOrb has for Real-World Evidence Generation and Evaluation of Therapeutics.
Who wrote Real-World Evidence Generation and Evaluation of Therapeutics?
Real-World Evidence Generation and Evaluation of Therapeutics is by Health and Medicine Division, Board on Health Sciences Policy, and Anne B. Claiborne.